In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles.

The biological investigation and detection of esophageal cancers could be facilitated with an endoscopic technology to screen for the molecular changes that precede and accompany the onset of cancer. Surface-enhanced Raman scattering (SERS) nanoparticles (NPs) have the potential to improve cancer detection and investigation through the sensitive and multiplexed detection of cell-surface biomarkers. Here, we demonstrate that the topical application and endoscopic imaging of a multiplexed cocktail of receptor-targeted SERS NPs enables the rapid detection of tumors in an orthotopic rat model of esophageal cancer. Antibody-conjugated SERS NPs were topically applied on the lumenal surface of the rat esophagus to target EGFR and HER2, and a miniature spectral endoscope featuring rotational scanning and axial pull-back was employed to comprehensively image the NPs bound on the lumen of the esophagus. Ratiometric analyses of specific vs. nonspecific binding enabled the visualization of tumor locations and the quantification of biomarker expression in agreement with immunohistochemistry and flow cytometry validation data.

[1]  Christopher H Contag,et al.  Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy. , 2009, Biophysical journal.

[2]  Sanjiv S. Gambhir,et al.  Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy , 2009, Proceedings of the National Academy of Sciences.

[3]  E. Kornilova,et al.  EGF receptor and p185erbB‐2‐specific single‐chain antibody toxins differ in their cell‐killing activity on tumor cells expressing both receptor proteins , 1995, International journal of cancer.

[4]  Jesse V Jokerst,et al.  A small animal Raman instrument for rapid, wide-area, spectroscopic imaging , 2013, Proceedings of the National Academy of Sciences.

[5]  Daphne Meza,et al.  Comprehensive spectral endoscopy of topically applied SERS nanoparticles in the rat esophagus. , 2014, Biomedical optics express.

[6]  P. Lopez,et al.  Esophageal cancer: a review and update. , 2006, American family physician.

[7]  B. Groner,et al.  A bivalent single‐chain antibody‐toxin specific for ErbB‐2 and the EGF receptor , 1996, International journal of cancer.

[8]  R. G. Freeman,et al.  SERS as a Foundation for Nanoscale, Optically Detected Biological Labels , 2007 .

[9]  Christopher H Contag,et al.  A Raman-based endoscopic strategy for multiplexed molecular imaging , 2013, Proceedings of the National Academy of Sciences.

[10]  Ximei Qian,et al.  Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. , 2011, Cancer research.

[11]  Andrew A Berlin,et al.  Composite organic-inorganic nanoparticles as Raman labels for tissue analysis. , 2007, Nano letters.

[12]  Rebecca C Fitzgerald,et al.  Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus , 2012, Nature Medicine.

[13]  C. Miller,et al.  Incidence and Survival Trends of Esophageal Carcinoma in the United States: Racial and Gender Differences by Histological Type , 2002, Scandinavian journal of gastroenterology.

[14]  Jason R. Gunn,et al.  In Vivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging , 2012, Molecular Imaging and Biology.

[15]  Eun Kyu Lee,et al.  Fabrication of SERS-fluorescence dual modal nanoprobes and application to multiplex cancer cell imaging. , 2012, Nanoscale.

[16]  Steven Y. Leigh,et al.  Method for Assessing the Reliability of Molecular Diagnostics Based on Multiplexed SERS-Coded Nanoparticles , 2013, PloS one.

[17]  Jesse V Jokerst,et al.  Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor. , 2011, Small.

[18]  N. Rosen,et al.  The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. , 2001, Cancer research.

[19]  Bing Yan,et al.  SERS tags: novel optical nanoprobes for bioanalysis. , 2013, Chemical reviews.

[20]  B. Neel,et al.  Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways. , 2003, Molecular cancer research : MCR.

[21]  Andrew A Berlin,et al.  Composite organic-inorganic nanoparticles (COINs) with chemically encoded optical signatures. , 2005, Nano letters.

[22]  C. Bascoul-Mollevi,et al.  Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers , 2011, The Journal of Biological Chemistry.

[23]  Jesse D. Martinez,et al.  Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa'). , 2003, Cancer letters.

[24]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[25]  Brian C Wilson,et al.  Filter-based method for background removal in high-sensitivity wide-field-surface-enhanced Raman scattering imaging in vivo. , 2012, Journal of biomedical optics.

[26]  Nathan O. Loewke,et al.  A Real-Time Clinical Endoscopic System for Intraluminal, Multiplexed Imaging of Surface-Enhanced Raman Scattering Nanoparticles , 2015, PloS one.

[27]  Robert Sinclair,et al.  The Fate and Toxicity of Raman-Active Silica-Gold Nanoparticles in Mice , 2011, Science Translational Medicine.

[28]  A. Polednak,et al.  Trends in survival for both histologic types of esophageal cancer in U.S. surveillance, epidemiology and end results areas , 2003, International journal of cancer.

[29]  Tayyaba Hasan,et al.  Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. , 2012, Journal of biomedical optics.

[30]  Rebecca Richards-Kortum,et al.  Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. , 2012, Nanomedicine.

[31]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[32]  R. Souza.  Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma. , 2002, Surgical oncology clinics of North America.

[33]  Christopher H Contag,et al.  High-sensitivity, real-time, ratiometric imaging of surface-enhanced Raman scattering nanoparticles with a clinically translatable Raman endoscope device , 2013, Journal of biomedical optics.

[34]  Thomas D. Wang,et al.  Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results , 2013, Science Translational Medicine.

[35]  Robert Sinclair,et al.  Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging. , 2011, Small.

[36]  S. Gambhir,et al.  Noninvasive molecular imaging of small living subjects using Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[37]  R. Tsien,et al.  Fluorescence-guided surgery with live molecular navigation — a new cutting edge , 2013, Nature Reviews Cancer.

[38]  Brian C Wilson,et al.  Widefield quantitative multiplex surface enhanced Raman scattering imaging in vivo , 2013, Journal of biomedical optics.